Skip to main content
FB

Fawkes Biodata

This platform aggregates patient medical records automatically to streamline access to personal health data. It uses this history to provide personalized answers to patient health inquiries. The service then matches individuals to relevant clinical trials based on their documented medical profile.

Toronto, CanadaFounded 20242500+ followers
Updated 4 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Product

Problem

Pharmaceutical companies face challenges in obtaining comprehensive, longitudinal patient data for clinical trials and research, often relying on fragmented sources that lack patient consent and structured formatting. This can lead to inefficiencies in drug development and limit the potential for personalized medicine approaches.

Solution

Fawkes Biodata is a medical data aggregation and analytics platform that facilitates the secure and consented sharing of patient-owned health data with pharmaceutical companies. The platform collects and structures longitudinal data from various healthcare providers and research institutions, ensuring data integrity and patient privacy through advanced encryption and adherence to data protection regulations. By providing access to comprehensive, real-world data, Fawkes Biodata enhances the accuracy of clinical trials, accelerates drug development, and supports personalized patient support programs. The platform also incorporates AI tools to enable the training, fine-tuning, and integration of AI-based healthcare solutions.

Target Audience

The primary customers are pharmaceutical companies and clinical research organizations seeking comprehensive, patient-consented data to improve clinical trials, accelerate drug development, and develop personalized medicine approaches. Fawkes Biodata also targets healthcare providers and research institutions looking to contribute data to advance medical research.

Features

  • Aggregates patient data from reputable and compliant healthcare providers and research institutions.
  • Employs advanced encrypted databases to ensure the utmost security for sensitive medical data.
  • Provides structured, longitudinal medical data suitable for AI training and integration.
  • Facilitates real-world data studies to support clinical development, medical affairs, and market access studies.
  • Offers personalized, consented, patient-owned support with scalable integration between patient, provider, and manufacturer.
  • Enables seamless data retrieval in real-time to expedite pharmaceutical research with patient consent and compensation.
This profile is AI-generated and may contain inaccuracies.